Dogwood Therapeutics Inc (DWTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,350 | -4,622 | -2,341 | -1,291 | -5,296 |
| Depreciation Amortization | 71 | N/A | N/A | N/A | N/A |
| Income taxes - deferred | -1 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 220 | 343 | 36 | 85 | -461 |
| Other Working Capital | -581 | 1,580 | 304 | 215 | -194 |
| Other Operating Activity | 3,850 | 39 | 252 | 54 | 1,081 |
| Operating Cash Flow | $-8,791 | $-2,659 | $-1,749 | $-937 | $-4,871 |
| Cash Flows From Investing Activities | |||||
| Net Acquisitions | 3,762 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $3,762 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 15,323 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 1,382 | 1,382 | 1,452 | N/A | 1,156 |
| Financing Cash Flow | $16,705 | $1,382 | $1,452 | $N/A | $1,156 |
| Exchange Rate Effect | -145 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 3,317 | 3,317 | 3,317 | 3,317 | 7,031 |
| End Cash Position | 14,848 | 2,040 | 3,020 | 2,380 | 3,317 |
| Net Cash Flow | $11,531 | $-1,277 | $-297 | $-937 | $-3,714 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,791 | -2,659 | -1,749 | -937 | -4,871 |
| Free Cash Flow | -8,791 | -2,659 | -1,749 | -937 | -4,871 |